Thanks to You,
Awareness Day Was a Success!

Read Here

TAYSHA GENE THERAPIES
RECEIVES RARE PEDIATRIC DISEASE
AND ORPHAN DRUG DESIGNATIONS
FOR SLC13A5 DEFICIENCY

Read Here

Newly diagnosed?

Join our registry!

TESS Research Foundation

​​Our Goal is to find treatments for the genetic disease SLC13A5 Deficiency.

TESS Research Foundation is a 501(c)(3) tax exempt public charity. Our mission is to help families affected by SLC13A5 Deficiency. SLC13A5 Deficiency (aka Citrate Transporter Disorder) is a newly discovered genetic cause of epilepsy, and as such, TESS Research Foundation is building a patient-centered network from the ground up. We are determined to diagnose, treat, and ultimately cure SLC13A5 Deficiency. We do this by funding cutting-edge research and connecting families, doctors, and researchers.

Ellie's Superhero Story

COVID Vaccines and Gene Therapy

/
Authors: This statement was modified with permission from a statement…

What is it like to live with epilepsy? - Interview with Kathryn

/
  Hi Kathryn! Please tell us a little about yourself and…

Subscribe to Updates

Tax Information

TESS Research Foundation

A 501(c)(3) nonprofit corporation

Tax ID Number: 47-3108868

Treatments for Epilepsy and Symptoms of SLC13A5

Contact Information

Kimberly Nye
655 Oak Grove Ave #53
Menlo Park, CA 94026

(650) 521-2279

E-Mail Kim